Quiero centrarme en un efecto adverso que, sin ser el ms frecuente, se est viendo cada vez ms en las consultas (debido al cada vez ms extenso uso de arGLP-1), sobre todo en pacientes obesos o con sobrepeso (no tanto en diabticos): el estreimiento
5-minute readPublished 05/15/2026Updated 11:10 AM EST, 06/08/2026 What is the Medicare GLP-1 Bridge
GLP-1 receptor agonists slow gastric emptying, potentially leaving food in the stomach beyond standard fasting periods
CJC-1295 is a synthetic analogue of growth hormone-releasing hormone (GHRH) the naturally occurring peptide that signals the pituitary gland to release growth hormone
"And that's why we see a lot of the effects that we see." "It's important to do it the right way and really treat these drugs with respect, treat your body with respect, and understand that this is a wonderful tool if it's used the right way."
To comply: the study director must be the single point of control with responsibility for: Approval of the study protocol and any changes Accurate recording and verification of all experimental data, including observations of unanticipated responses of the test system Documentation and correction of unforeseen circumstances that may affect the quality and integrity of the study Ensuring test systems are as specified in the protocol and that GLP is followed Transfer of raw data, documentation, protocols, specimens, and final reports to the archives
